Ciprofloxacin (Pfizer Labs, Division of Pfizer Inc)
Welcome to the PulseAid listing for the Ciprofloxacin drug offered from Pfizer Labs, Division of Pfizer Inc. This Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Labs, Division of Pfizer Inc |
NON-PROPRIETARY NAME: | Ciprofloxacin |
SUBSTANCE NAME: | CIPROFLOXACIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-09-11 |
END MARKETING DATE: | 0000-00-00 |
Ciprofloxacin HUMAN PRESCRIPTION DRUG Details:
Item Description | Ciprofloxacin from Pfizer Labs, Division of Pfizer Inc |
LABELER NAME: | Pfizer Labs, Division of Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2009-09-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-3241_e916bb8c-38ef-4f8c-ac32-254013339e33 |
PRODUCT NDC: | 0069-3241 |
APPLICATION NUMBER: | ANDA078062 |
Other CIPROFLOXACIN Pharmaceutical Manufacturers / Labelers: